| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to treatment for hepatitis B virus infection—Worldwide, 2016
|
Hutin, Yvan
|
|
|
18 |
10 |
p. 2595-2598
|
artikel
|
| 2 |
American Journal of Transplantation: Volume 18, Number 10, October 2018
|
|
|
|
18 |
10 |
p. i
|
artikel
|
| 3 |
Are we underestimating the quality of aviremic hepatitis C–positive kidneys? Time to reconsider
|
Sibulesky, L.
|
|
|
18 |
10 |
p. 2465-2472
|
artikel
|
| 4 |
Belatacept rescue for delayed kidney allograft function in a patient with previous combined heart-liver transplant
|
Kumar, Dhiren
|
|
|
18 |
10 |
p. 2613-2614
|
artikel
|
| 5 |
Can we mitigate the effects of simultaneous liver-kidney transplantation through increased utilization of HCV-positive donors?
|
Sibulesky, Lena
|
|
|
18 |
10 |
p. 2604-2605
|
artikel
|
| 6 |
Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study
|
Chascsa, D.M.
|
|
|
18 |
10 |
p. 2559-2565
|
artikel
|
| 7 |
Consent and labeling in the use of infectious risk donor kidneys: A response to “Information Overload”
|
Bowring, Mary G.
|
|
|
18 |
10 |
p. 2608-2609
|
artikel
|
| 8 |
Cost-effectiveness of hepatitis C–positive donor kidney transplantation for hepatitis C–negative recipients with concomitant direct-acting antiviral therapy
|
Gupta, Gaurav
|
|
|
18 |
10 |
p. 2496-2505
|
artikel
|
| 9 |
Cost-effectiveness of using kidneys from hepatitis C nucleic acid test–positive donors for transplantation in hepatitis C–negative recipients
|
Kadatz, Matthew
|
|
|
18 |
10 |
p. 2457-2464
|
artikel
|
| 10 |
Danger, Metabolism and T Cell Memory
|
Alegre, Maria-Luisa
|
|
|
18 |
10 |
p. 2375
|
artikel
|
| 11 |
Dietary Approach to Stop Hypertension (DASH) diet and risk of renal function decline and all-cause mortality in renal transplant recipients
|
Osté, Maryse C.J.
|
|
|
18 |
10 |
p. 2523-2533
|
artikel
|
| 12 |
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
|
Manzardo, Christian
|
|
|
18 |
10 |
p. 2513-2522
|
artikel
|
| 13 |
Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post–lung transplant
|
Cheng, Qi
|
|
|
18 |
10 |
p. 2417-2428
|
artikel
|
| 14 |
Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review.
|
Boteon, Yuri L.
|
|
|
18 |
10 |
p. 2384-2399
|
artikel
|
| 15 |
Gastrointestinal hemorrhage in a liver transplant recipient
|
Schielke, Astrid
|
|
|
18 |
10 |
p. 2599-2601
|
artikel
|
| 16 |
GFR-related risks for kidney donors are here to stay, but what are they?
|
Steiner, Robert
|
|
|
18 |
10 |
p. 2612
|
artikel
|
| 17 |
Graft-versus-host disease of the central nervous system after liver transplantation: A rare complication
|
Pahari, Hirak
|
|
|
18 |
10 |
p. 2591-2594
|
artikel
|
| 18 |
Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index
|
Tapper, Elliot B.
|
|
|
18 |
10 |
p. 2566-2570
|
artikel
|
| 19 |
Hepatitis C Infection May Be a Blessing for Patients in Need of a Transplant
|
Pullen, Lara C.
|
|
|
18 |
10 |
p. 2373-2374
|
artikel
|
| 20 |
Hepatitis C virus–infected kidney waitlist patients: Treat now or treat later?
|
Kiberd, B.A.
|
|
|
18 |
10 |
p. 2443-2450
|
artikel
|
| 21 |
High tacrolimus trough level variability is associated with rejections after heart transplant
|
Gueta, Itai
|
|
|
18 |
10 |
p. 2571-2578
|
artikel
|
| 22 |
Hypertension after kidney donation: Incidence, predictors, and correlates
|
Sanchez, Otto A.
|
|
|
18 |
10 |
p. 2534-2543
|
artikel
|
| 23 |
If hepatitis C therapy is so great, why isn’t everyone doing it?
|
Brown Jr, Robert S.
|
|
|
18 |
10 |
p. 2382-2383
|
artikel
|
| 24 |
Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy
|
Chan, Christine
|
|
|
18 |
10 |
p. 2506-2512
|
artikel
|
| 25 |
Information overload; a response to “Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys”
|
Singh, Pooja
|
|
|
18 |
10 |
p. 2606-2607
|
artikel
|
| 26 |
Maximizing utilization of the donor pool by appropriate classification of hepatitis C antibody–positive donors
|
Goldberg, David S.
|
|
|
18 |
10 |
p. 2380-2381
|
artikel
|
| 27 |
Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients
|
Okano, Shinji
|
|
|
18 |
10 |
p. 2544-2558
|
artikel
|
| 28 |
Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act
|
Durand, Christine M.
|
|
|
18 |
10 |
p. 2579-2586
|
artikel
|
| 29 |
Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation
|
Shelton, Brittany A.
|
|
|
18 |
10 |
p. 2483-2495
|
artikel
|
| 30 |
Remission of type 1 diabetes mellitus recurrence 6 years after simultaneous pancreas and kidney transplantation
|
Kervella, Delphine
|
|
|
18 |
10 |
p. 2610-2611
|
artikel
|
| 31 |
Single nucleotide variant counts computed from RNA sequencing and cellular traffic into human kidney allografts
|
Thareja, Gaurav
|
|
|
18 |
10 |
p. 2429-2442
|
artikel
|
| 32 |
The future of marginal kidney repair in the context of normothermic machine perfusion
|
DiRito, Jenna R.
|
|
|
18 |
10 |
p. 2400-2408
|
artikel
|
| 33 |
The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes
|
Axelrod, D.A.
|
|
|
18 |
10 |
p. 2473-2482
|
artikel
|
| 34 |
The road map toward an hepatitis C virus-free transplant population
|
Berenguer, M.
|
|
|
18 |
10 |
p. 2409-2416
|
artikel
|
| 35 |
Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia
|
de Vera, Michael E.
|
|
|
18 |
10 |
p. 2451-2456
|
artikel
|
| 36 |
TRANSPLANTATION PATHOLOGY SECOND EDITION P. Ruiz (Editor) Cambridge, UK: Cambridge University Press, 2018, 386 pages.
|
Haas, Mark
|
|
|
18 |
10 |
p. 2602-2603
|
artikel
|
| 37 |
Very late relapse of hepatitis C virus infection immediately after liver transplant
|
Erard-Poinsot, Domitille
|
|
|
18 |
10 |
p. 2587-2590
|
artikel
|
| 38 |
Where have all the (HCV-positive) kidneys gone?
|
Sawinski, Deirdre
|
|
|
18 |
10 |
p. 2377-2379
|
artikel
|
Tijdschrift beschrijving